华南预防医学 ›› 2026, Vol. 52 ›› Issue (7): 812-818.doi: 10.12183/j.scjpm.2026.0812

• 论著 • 上一篇    下一篇

新型冠状病毒弗林酶切位点缺失分子机制研究

刘哲1, 邱明2, 颜羽西1, 曹嘉钿1, 李淑伶1, 邓雯雯1, 何雨蔚1, 向思霖1, 曾楚婷1, 龙鹤师1, 陆靖1   

  1. 1.广东省疾病预防控制中心 广东省公共卫生研究院,广东 广州 511430;
    2.成都市疾病预防控制中心
  • 收稿日期:2025-12-24 出版日期:2026-07-20 发布日期:2026-08-07
  • 通讯作者: 陆靖,E-mail:jimlu0331@163.com
  • 作者简介:刘哲(1984—),男,博士研究生,副主任技师,主要从事传染病病原检测及方法开发等工作;邱明(1999—),男,硕士研究生,医师,主要从事传染病流行病学模型构建与进化机制等工作;刘哲和邱明同为第一作者
  • 基金资助:
    广东省基础与应用基础研究基金项目(2023A1515011927); 广东省疾病预防控制中心立项支持人才项目(0720240122)

Molecular mechanism of Furin cleavage site deletion in SARS-CoV-2

Liu Zhe1, Qiu Ming2, Yan Yuxi1, Cao Jiatian1, Li Shuling1, Deng Wenwen1, He Yuwei1, Xiang Silin1, Zeng Chuting1, Long Heshi1, Lu Jing1   

  1. 1. Guangdong Provincial Center for Disease Control and Prevention, Guangdong Provincial Institute of Public Health, Guangzhou, Guangdong 511430, China;
    2. Chengdu Provincial Center for Disease Control and Prevention
  • Received:2025-12-24 Online:2026-07-20 Published:2026-08-07

摘要: 目的 探讨新型冠状病毒(SARS-CoV-2)体外培养过程中弗林酶切位点(Furin Cleavage Site,FCS)缺失的分子机制,分析其对病毒起源与进化的生物学意义。方法 将SARS-CoV-2原型株及多种变异株在Vero E6和293T-hACE2细胞系中连续传代;应用多重PCR扩增子高通量测序技术,动态监测FCS区域及其侧翼序列的变异特征;通过药物抑制跨膜丝氨酸蛋白酶2(TMPRSS2)途径,分析FCS缺失与病毒入侵方式及基因组特定位点的关联;结合全球公共数据库序列进行系统发育分析。结果 体外连续传代实验显示,除B.1、Alpha和Omicron及其亚分支外,其他SARS-CoV-2进化分支毒株均发生快速的FCS序列缺失。噬斑纯化的B.1型毒株在2种细胞系连续传代6代(P6)后,虽未直接检测到FCS缺失,但S蛋白基因23525位点均演化出T/C混合准种,且突变频率随代次递增。在阻断TMPRSS2依赖的细胞表面入侵途径后,FCS缺失突变株迅速出现并富集,至P6代已成为优势种群(丰度达57.9%)。序列分析证实,FCS缺失与上游23422及23525位点的T>C协同突变存在严格共现关系,提示该双位点胞嘧啶(C)基因型可能是FCS缺失的前置分子事件。数据库分析进一步表明,23422位点在人群中高度保守,而23525位点呈现谱系特异性:早期流行株(如Delta)多为23525C,易发生FCS缺失;后期流行株(如Omicron)多为23525T,FCS相对稳定,与体外实验表型高度一致。结论 SARS-CoV-2体外复制过程中的FCS缺失具有显著的序列特异性,上游23422与23525位点同时存在的胞嘧啶(C)基因型可能是诱导该区域缺失的关键分子前提。本研究揭示了FCS稳定性的分子决定因素,为阐明SARS-CoV-2跨物种传播适应性机制及分子演化规律提供了重要依据。

关键词: 新型冠状病毒, 弗林酶切位点, 缺失机制, 高通量测序

Abstract: Objective To investigate the molecular mechanisms underlying the deletion of the Furin Cleavage Site (FCS) during in vitro culturing of SARS-CoV-2 and to analyze the biological significance of this phenomenon for the virus's origin and evolution. Methods The prototype strain and various mutant strains of SARS-CoV-2 were serially passaged in Vero E6 and 293T-hACE2 cell lines. High-throughput sequencing of multiplex PCR amplicons was employed to dynamically monitor the variation characteristics of the FCS region and its flanking sequences. The association between FCS deletion, the viral entry pathway, and specific genomic loci was analyzed by pharmacologically inhibiting the Transmembrane Serine Protease 2 (TMPRSS2) pathway. Phylogenetic analysis was conducted in conjunction with sequences from global public databases. Results The in vitro serial passage experiments demonstrated that, with the exception of B.1、Alpha, Omicron, and their sublineages, all other tested SARS-CoV-2 evolutionary branches underwent rapid deletion of the FCS sequence. Although direct FCS deletion was not detected after six passages (P6) of plaque-purified B.1 virus in both cell lines, a mixed T/C quasispecies emerged at position 23525 of the spike (S) protein gene, with its mutation frequency increasing with successive passages. Following the blockade of the TMPRSS2-dependent cell surface entry pathway, mutant strains with FCS deletions rapidly appeared and were enriched, becoming the dominant population (reaching an abundance of 57.9%) by P6. Sequence analysis confirmed a strict co-occurrence of the FCS deletion with synergistic T>C mutations at upstream positions 23422 and 23525, indicating that a cytosine (C) genotype at this dual-locus is possibly a prerequisite molecular event for the FCS deletion. Database analysis further revealed that position 23422 is highly conserved in human populations, whereas position 23525 exhibits lineage-specificity: early epidemic strains (e.g., Delta) predominantly carried 23525C and were prone to FCS deletion, while later strains (e.g., Omicron) predominantly featured 23525T with a relatively stable FCS, observations that are highly consistent with the in vitro experimental phenotypes. Conclusion The deletion of the FCS during in vitro replication of SARS-CoV-2 exhibits marked sequence specificity. The concurrent presence of a cytosine (C) genotype at the upstream 23422 and 23525 loci is possibly a critical molecular precondition that induces the deletion in this region. This study elucidates the molecular determinants of FCS stability, providing a significant basis for clarifying the adaptive mechanisms of SARS-CoV-2 in cross-species transmission and its molecular evolutionary patterns.

Key words: SARS-CoV-2, Furin cleavage site (FCS), Deletion mechanism, High-throughput sequencing

中图分类号: 

  • R373